Literature DB >> 8500798

A 40-nucleotide repeat polymorphism in the human dopamine transporter gene.

A Sano1, K Kondoh, Y Kakimoto, I Kondo.   

Abstract

A new polymorphic 40-nucleotide repeat in the human dopamine transporter gene is described. It may underlie individual differences in susceptibility to several neuropsychiatric diseases.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8500798     DOI： 10.1007/BF00217369

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  2 in total

1.  A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs.

Authors:  D J Vandenbergh; A M Persico; G R Uhl
Journal:  Brain Res Mol Brain Res       Date:  1992-09

2.  Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

Authors:  S Shimada; S Kitayama; C L Lin; A Patel; E Nanthakumar; P Gregor; M Kuhar; G Uhl
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728
  2 in total
  22 in total

1.  Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.

Authors:  Ramesh C Juyal; Mitashree Das; Sohan Punia; Madhuri Behari; Geetika Nainwal; Sumit Singh; Pazhayannur V Swaminath; Shyla T Govindappa; Sachi Jayaram; Uday B Muthane; B K Thelma
Journal:  Neurogenetics       Date:  2006-07-01       Impact factor: 2.660

Review 2.  Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system.

Authors:  Michelle A Patriquin; Isabelle E Bauer; Jair C Soares; David P Graham; David A Nielsen
Journal:  Psychiatr Genet       Date:  2015-10       Impact factor: 2.458

3.  An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects.

Authors:  S J Kim; Y S Kim; H S Lee; S Y Kim; C-H Kim
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

4.  Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations.

Authors:  L V K S Bhaskar; Kumarasamy Thangaraj; Connie J Mulligan; Samiksha Wasnik; Amrita Nandan; Varun Kumar Sharma; Vishwas Sharma; Alla Govardhana Reddy; Lalji Singh; Vadlamudi Raghavendra Rao
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

5.  miR-137 and miR-491 Negatively Regulate Dopamine Transporter Expression and Function in Neural Cells.

Authors:  Xiaojian Jia; Feng Wang; Ying Han; Xuewen Geng; Minghua Li; Yu Shi; Lin Lu; Yun Chen
Journal:  Neurosci Bull       Date:  2016-09-15       Impact factor: 5.203

6.  Genetic determinants of time perception mediated by the serotonergic system.

Authors:  Olga V Sysoeva; Alexander G Tonevitsky; Jirí Wackermann
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

Review 7.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

8.  Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Francine Z C Marques; Guilherme P Bertuzzi; Carlos A I Salgado; Katiane L Silva; Nyvia O Sousa; Eugenio H Grevet; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2010-01-05       Impact factor: 3.575

9.  Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Authors:  Alicja Sieminska; Krzysztof Buczkowski; Ewa Jassem; Marek Niedoszytko; Ewa Tkacz
Journal:  BMC Med Genet       Date:  2009-09-17       Impact factor: 2.103

10.  Time-resolved influences of functional DAT1 and COMT variants on visual perception and post-processing.

Authors:  Stephan Bender; Thomas Rellum; Christine Freitag; Franz Resch; Marcella Rietschel; Jens Treutlein; Christine Jennen-Steinmetz; Daniel Brandeis; Tobias Banaschewski; Manfred Laucht
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.